Varlilumab: A Deep Dive into CDX-1127 and its Mechanism The antibody (formerly known as compound CDX-1127) represents a novel therapeutic molecule targeting CD27. The drug's function relies on engagement to CD27, a https://www.targetmol.com/compound/varlilumab